UNH · 10-Q · 2026Q2 · Full report

Liquidity and Cash Position

UNITEDHEALTH GROUP INC · 2026-08-10 · Importance 49 · Surprise 6 · In source text

At June 30, 2026, cash, cash equivalents, available-for-sale debt securities and marketable equity securities totaled $81.0 billion. The balance included $28.6 billion of cash and cash equivalents, of which only $1.1 billion was available for general corporate use, plus $50.3 billion of debt securities and $2.1 billion of marketable equity securities. Loan receivables totaled $10.8 billion, and the available-for-sale debt portfolio had a 4.1-year weighted-average duration and Double-A weighted-average credit rating. Net cash and cash equivalents increased $4.220 billion during the first six months.

Key facts

• Total sources of cash for the six months ended June 30, 2026 were $22,142 million compared to $17,520 million for the six months ended June 30, 2025, an increase of $4,622 million. source
• Of the $28.6 billion of cash and cash equivalents as of June 30, 2026, $1.1 billion was available for general corporate use. source
• Our available-for-sale debt securities, marketable equity securities and cash and cash equivalents balances were $81.0 billion as of June 30, 2026, including $28.6 billion of cash and cash equivalents. source
• Total uses of cash for the six months ended June 30, 2026 were $18,038 million compared to $14,240 million for the six months ended June 30, 2025, an increase of $3,798 million. source
• Available-for-sale debt securities portfolio had a weighted-average duration of 4.1 years and a weighted-average credit rating of “Double A” as of June 30, 2026. source

Impact estimates